Dallan Murray, Chief Officer of Sarepta Therapeutics SRPT, has filed 0 purchases and 1 sale on the open market. The latest trade was on 25/03/10.

DM

DM

Dallan Murray

Chief Customer Officer

Company

Sarepta Therapeutics SRPT

First filing

24/05/06

Trades

19 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

25/03/10

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Sarepta TherapeuticsSRPT	Open-market sale10b5-1 plan	24/05/02	24/05/06	3,635 sh	$140.00	$508,900	−16.7%